Gastro Health Sold to OMERS Private Equity

Gastro Health Sold to OMERS Private Equity

One of the largest gastrointestinal physician groups has been sold to a Canadian private equity firm. OMERS Private Equity, based in Toronto, has purchased Gastro Health, LLC from Audax Private Equity. No terms were disclosed. Gastro Health is a medical group specializing in the treatment of gastrointestinal disorders, nutrition and digestive health. The group has more than 250 physicians with locations in Alabama, Florida, Maryland, Ohio, Virginia and Washington.  Audax Private Equity has sponsored Gastro Health since it acquired them in 2016, and the partnership has produced nearly 20 transactions, including two this year. In March, the physician group purchased Digestive Disease... Read More »
ResMed Pays Big for MatrixCare

ResMed Pays Big for MatrixCare

It’s a frothy, frothy market in most areas of health care, and the digital health space just got frothier. ResMed Inc. (NYSE: RMD), which makes medical equipment to monitor respiratory disorders, announced it paid $750 million for MatrixCare, a portfolio company of OMERS Private Equity. Right up front, ResMed touted the 25x price/EBITDA multiple, based on MatrixCare’s pro forma net EBITDA of approximately $30 million for calendar year 2018. Pro forma net revenue of $122 million in the same period is approximately 6.2x. The valuation is higher than even the sector’s biggest deal this year, Verscend Technologies’ $4.9 billion take-private deal for Cotiviti Holdings... Read More »